Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement
Titel:
Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement
Auteur:
Schwab, Richard Petak, Istvan Kollar, Mihaly Pinter, Ferenc Varkondi, Edit Kohanka, Andrea Barti-Juhasz, Helga Schönleber, Julia Brauswetter, Diana Kopper, Laszlo Urban, Laszlo